On ECHEMI
Home > Drugs > Methazolamide Registered Holders
Methazolamide structure

Methazolamide structure

Methazolamide

Methazolamide is a carbonic anhydrase inhibitor used to treat glaucoma.Target: Carbonic AnhydraseMethazolamide is a carbonic anhydrase inhibitor with Ki of 50 nM, 14 nM and 36 nM for hCA I, hCA II and bCA IV isoforms, respectively [1]. Methazolamide is of strength equal to acetazolamide, another carbonic anhydrase inhibitor used to treat irregular breathing disorders. However, methazolamide differs from acetazolamide in that it fails to activate Ca2+-dependent potassium channels in skele

Find 8 Related Holders

MICRO LABS LTD
United States United States

API Registration Country

API Active
BIOPHORE INDIA PHARMACEUTICALS PVT LTD
United States United States

API Registration Country

API Active
FINE CHEMICALS CORP PTY LTD
United States United States

API Registration Country

API Active
DELMAR CHEMICALS INC.
United States United States

API Registration Country

API Active
  • Founded in:

    1967-04-07 00:00:00
  • Country:

    United States United States
  • Email:

Yikelai (Taizhou) Pharmaceutical Co., Ltd.
China China

API Registration Country

API Active
  • Founded in:

    2016-06-08
  • Country:

    China China
  • Address:

    No. 25, Donghai Fifth Avenue, Linhai Medical and Chemical Park, Zhejiang Chemical API Base, Linhai City, Taizhou City
  • Tax NO.:

    91331082MA28GGB92T
  • Registered Funds:

    100 million yuan
  • Email:

CHEMISCHE FABRIK WEYL GMBH
United States United States

API Registration Country

API Inactive
TCI AMERICA
United States United States

API Registration Country

API Inactive
CHONGQING NO. 5 PHARM. FACTORY
United States United States

API Registration Country

API Inactive
Recommended Suppliers of Methazolamide
View 22 Suppliers Request for Quotation
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.